EUVIMEDEUVIMED entdecken
Crossref

Saikosaponin D from Bupleurum targets SaeR to disrupt biofilm formation and pathogenic programs for the treatment of MRSA pneumonia

Shidong Zhang, Yanhe Luan, Li Wang, Luanbiao Sun, Peitong Jiang, Dongbin Guo, Bingmei Wang, Yicheng Zhao, Yanming Jiang, Da Liu

Biochemical Pharmacology · 2026

DOI: 10.1016/j.bcp.2025.117640 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026. Verfasst von Shidong Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Changchun University of Chinese Medicine, Changchun, China; ZHONGKEJUYAN Stem Cell Company Ltd, Changchun, China. Hauptthemen laut MEDLINE: Biofilms, Saponins, Oleanolic Acid, Methicillin-Resistant Staphylococcus aureus. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Jilin Provincial Scientific and Technological Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Staphylococcus aureus pneumonia, particularly methicillin-resistant Staphylococcus aureus (MRSA), remains a major clinical challenge due to biofilm formation, complex regulatory programs, and rapid acquisition of antimicrobial resistance (AMR). The SaeRS two-component system is a central regulatory node controlling multiple infection-related pathways, making its response regulator SaeR an attractive therapeutic target. Targeting such upstream regulators provides an alternative strategy to conventional bactericidal approaches. Through a network pharmacology-guided screen, we identified saikosaponin D (SSD), an oleanane-type pentacyclic triterpenoid saponin from Bupleurum, as a candidate compound. Biophysical and biochemical assays, including cellular thermal shift assay (CETSA), surface plasmon resonance (SPR), and electrophoretic mobility shift assay (EMSA), demonstrated that SSD directly binds SaeR and impairs its DNA-binding capacity. This interference repressed SaeR-dependent transcription, resulting in reduced α-hemolysin and Panton-Valentine leucocidin (PVL) production, diminished hemolytic activity, decreased bacterial adhesion and invasion, and disruption of biofilm integrity through suppression of extracellular matrix components. In vivo, SSD conferred significant protection in both invertebrate and mammalian infection models. In Galleria mellonella, SSD improved survival, and in a murine model of MRSA pneumonia, SSD reduced pulmonary bacterial burden, alleviated inflammation and edema, and enhanced overall survival. Collectively, these findings establish SaeR as a druggable upstream regulator and highlight SSD as a natural product scaffold with translational potential for therapeutic development against MRSA infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiofilmsSaponinsOleanolic AcidMethicillin-Resistant Staphylococcus aureusBupleurumBacterial ProteinsAnti-Bacterial AgentsPneumonia, StaphylococcalAnimalsMiceHumansMicrobial Sensitivity TestsDose-Response Relationship, Drug

Stichwörter der Autor:innen

BiofilmMRSANetwork pharmacologyPneumoniaSaeRSaikosaponin D

Substanzen

SaponinsOleanolic Acidsaikosaponin DBacterial ProteinsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Changchun University of Chinese Medicine, Changchun, China; ZHONGKEJUYAN Stem Cell Company Ltd, Changchun, China.
  • Department of General Surgery, Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, China.
  • Chinese Medicine Guangdong Laboratory /State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Clinical College, Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medic…
  • China-Japan Union Hospital of Jilin University, Changchun 130033, China.
  • Changchun University of Chinese Medicine, Changchun, China.
  • Changchun University of Chinese Medicine, Changchun, China; ZHONGKEJUYAN Stem Cell Company Ltd, Changchun, China. Electronic address: zkjygxb@163.com.

Förderung

  • Jilin Provincial Scientific and Technological Development Program

Zitieren

APA

Zhang, S., Luan, Y., Wang, L., Sun, L., Jiang, P., Guo, D., Wang, B., Zhao, Y., Jiang, Y., & Liu, D. (2026). Saikosaponin D from Bupleurum targets SaeR to disrupt biofilm formation and pathogenic programs for the treatment of MRSA pneumonia. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2025.117640

Vancouver

Zhang S, Luan Y, Wang L, Sun L, Jiang P, Guo D, et al. Saikosaponin D from Bupleurum targets SaeR to disrupt biofilm formation and pathogenic programs for the treatment of MRSA pneumonia. Biochemical Pharmacology. 2026. doi:10.1016/j.bcp.2025.117640

BibTeX
@article{Zhang2026,
  author = {Zhang, Shidong and Luan, Yanhe and Wang, Li and Sun, Luanbiao and Jiang, Peitong and Guo, Dongbin and Wang, Bingmei and Zhao, Yicheng and Jiang, Yanming and Liu, Da},
  title = {Saikosaponin D from Bupleurum targets SaeR to disrupt biofilm formation and pathogenic programs for the treatment of MRSA pneumonia},
  journal = {Biochemical Pharmacology},
  year = {2026},
  doi = {10.1016/j.bcp.2025.117640}
}
Kostenlos starten →